APD421
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for APD421, covering 2012-09-25 to 2019-08-02. Get the full timeline:
Most recent: Clinical Trial Update: European Phase III Study of APD421 in PONV [Phase 3]